Ultragenyx Pharmaceutical, a clinical-stage biopharmaceutical company, has appointed Karah Parschauer as general counsel. In this newly created role, she will be responsible for leading the company's legal, compliance, and corporate governance functions.

Before joining Ultragenyx, Parschauer spent 11 years at Allergan, most recently as associate general counsel. In this role, she served as head of legal and compliance for Allergan's Medical Aesthetic division and chief privacy officer. Prior to Allergan, Parschauer was an associate at Latham & Watkins, where she practiced in the areas of mergers and acquisitions, securities offerings, and corporate governance.